Lucid Diagnostics to Participate in Needham Healthcare Conference

The medical device company will discuss its latest developments in a virtual fireside chat.

Apr. 9, 2026 at 1:48pm

A ghostly, translucent X-ray image of a medical diagnostic device, revealing its intricate internal structure against a dark background.Lucid Diagnostics showcases its latest medical innovations at the Needham Healthcare Conference.NYC Today

Lucid Diagnostics Inc., a medical device company focused on early cancer detection, announced that it will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 9, 2026. The event will provide Lucid an opportunity to discuss its latest innovations and advancements in the field of early cancer screening.

Why it matters

Lucid Diagnostics is a promising player in the growing field of early cancer detection technologies. Its participation in high-profile industry events like the Needham Healthcare Conference allows the company to showcase its work and connect with potential investors, partners, and customers who are interested in cutting-edge medical innovations.

The details

During the fireside chat, Lucid Diagnostics executives will provide an overview of the company's products and pipeline, as well as discuss its strategic priorities and market opportunities. The virtual format of the conference allows for a more intimate dialogue between Lucid and conference attendees.

  • The 25th Annual Needham Virtual Healthcare Conference will take place on April 9, 2026.

The players

Lucid Diagnostics Inc.

A medical device company focused on developing technologies for the early detection of cancer.

Got photos? Submit your photos here. ›

What’s next

Following the conference, Lucid Diagnostics may provide updates on any new partnerships, product developments, or other milestones that emerge from its participation in the event.

The takeaway

Lucid Diagnostics' involvement in the Needham Healthcare Conference underscores its commitment to advancing early cancer detection solutions and engaging with key stakeholders in the medical technology industry.